https://www.selleckchem.com/pr....oducts/cilofexor-gs-
It has been observed to attain tight blood glucose control we need to increase insulin dose in group A from 45.5 ± 16.5 IU/Day to 51.5 ± 14.5 at week 12 (P0.01) and which further increased to 53.8 ± 12.8 IU/Day at week 24 (P0.01). Adding remogliflozin showed significant effect on blood pressure (P 0.001) and weight reduction (P 0.001). It has been observed that 38% patients has achieves targeted HbA1c (≤7%) in group B where it was 22% in group A. Results demonstrate that in uncontrolled T2DM patients remoglif
Like
Comment
Share
